Page last updated: 2024-08-21

chrysophanic acid and Adenoma, Prostatic

chrysophanic acid has been researched along with Adenoma, Prostatic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jeong, MY; Jung, Y; Kang, J; Kim, HL; Park, J; Seok Ahn, K; Sethi, G; Um, JY; Youn, DH	1

Other Studies

1 other study(ies) available for chrysophanic acid and Adenoma, Prostatic

Article	Year
Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase. Oncotarget, 2017, Feb-07, Volume: 8, Issue:6 Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Animals; Anthraquinones; Cell Line; Cell Proliferation; Disease Models, Animal; Down-Regulation; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Finasteride; Male; Nuclear Receptor Coactivator 1; Organ Size; Phosphorylation; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Rats, Sprague-Dawley; Receptors, Androgen; Signal Transduction; Testosterone Propionate; Time Factors	2017

Article

Year

Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.

Oncotarget, 2017, Feb-07, Volume: 8, Issue:6

Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Animals; Anthraquinones; Cell Line; Cell Proliferation; Disease Models, Animal; Down-Regulation; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Finasteride; Male; Nuclear Receptor Coactivator 1; Organ Size; Phosphorylation; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Rats, Sprague-Dawley; Receptors, Androgen; Signal Transduction; Testosterone Propionate; Time Factors

2017